{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:20:45Z","timestamp":1694625645689},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,28]],"date-time":"2006-02-28T00:00:00Z","timestamp":1141084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,2,28]],"date-time":"2006-02-28T00:00:00Z","timestamp":1141084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1038\/sj.pcan.4500861","type":"journal-article","created":{"date-parts":[[2006,2,28]],"date-time":"2006-02-28T09:54:57Z","timestamp":1141120497000},"page":"192-194","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Very late local recurrence after surgery for prostate cancer unaccompanied by detectable PSA levels"],"prefix":"10.1038","volume":"9","author":[{"given":"S","family":"Roemeling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J L H","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F H","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,28]]},"reference":[{"key":"BF4500861_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198710083171501","volume":"317","author":"TA Stamey","year":"1987","unstructured":"Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E . Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909\u2013916.","journal-title":"N Engl J Med"},{"key":"BF4500861_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0022-5347(01)61939-6","volume":"161","author":"J Oh","year":"1999","unstructured":"Oh J, Colberg JW, Ornstein DK, Johnson ET, Chan D, Virgo KS et al. Current follow up strategies after radical prostatectomy: a survey of American Urological Association Urologists. J Urol 1999; 161: 520\u2013523.","journal-title":"J Urol"},{"key":"BF4500861_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0022-5347(05)68280-8","volume":"162","author":"CR Pound","year":"1999","unstructured":"Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC . Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol 1999; 162: 1337\u20131340.","journal-title":"J Urol"},{"key":"BF4500861_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0046-8177(92)90108-F","volume":"23","author":"DF Gleason","year":"1992","unstructured":"Gleason DF . Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 273\u2013279.","journal-title":"Hum Pathol"},{"key":"BF4500861_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pros.2990210521","volume":"4","author":"FH Schroder","year":"1992","unstructured":"Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M . The TNM classification of prostate cancer. Prostate Suppl 1992; 4: 129\u2013138.","journal-title":"Prostate Suppl"},{"key":"BF4500861_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0022-5347(17)38998-X","volume":"142","author":"DE Goldrath","year":"1989","unstructured":"Goldrath DE, Messing EM . Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy. J Urol 1989; 142: 1082\u20131084.","journal-title":"J Urol"},{"key":"BF4500861_CR7","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0022-5347(01)66713-2","volume":"154","author":"MG Oefelein","year":"1995","unstructured":"Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A . The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol 1995; 154: 2128\u20132131.","journal-title":"J Urol"},{"key":"BF4500861_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.eururo.2005.07.006","volume":"48","author":"BJ Chaplin","year":"2005","unstructured":"Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH . Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Eur Urol 2005; 48: 906\u2013910.","journal-title":"Eur Urol"},{"key":"BF4500861_CR9","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1002\/1097-0142(19951215)76:12<2530::AID-CNCR2820761219>3.0.CO;2-F","volume":"76","author":"BD Leibman","year":"1995","unstructured":"Leibman BD, Dillioglugil O, Wheeler TM, Scardino PT . Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level. Cancer 1995; 76: 2530\u20132534.","journal-title":"Cancer"},{"key":"BF4500861_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0022-5347(17)36963-X","volume":"148","author":"TK Takayama","year":"1992","unstructured":"Takayama TK, Krieger JN, True LD, Lange PH . Recurrent prostate cancer despite undetectable prostate specific antigen. J Urol 1992; 148: 1541\u20131542.","journal-title":"J Urol"},{"key":"BF4500861_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1097-0045(19990215)38:3<183::AID-PROS2>3.0.CO;2-W","volume":"38","author":"RH Stege","year":"1999","unstructured":"Stege RH, Tribukait B, Carlstrom KA, Grande M, Pousette AH . Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate 1999; 38: 183\u2013188.","journal-title":"Prostate"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500861.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500861","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500861.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:03:54Z","timestamp":1648677834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,28]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6,1]]}},"alternative-id":["BF4500861"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500861","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,28]]},"assertion":[{"value":"23 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}